GKOS
Glaukos Corp
NYSE: GKOS · HEALTHCARE · MEDICAL DEVICES
$116.96
-2.23% today
Updated 2026-04-29
Market cap
$7.00B
P/E ratio
—
P/S ratio
13.80x
EPS (TTM)
$-3.28
Dividend yield
—
52W range
$73 – $130
Volume
0.7M
Glaukos Corp (GKOS) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$116.96
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$111.30
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.3B | $0.3B | $0.3B | $0.4B | $0.5B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -37.00%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.